ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Psychiatry

Top Psychiatry Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANDREW CHAN M.D.

Psychiatry

4,599

$531K

319
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $124

FRANK REYES MD

Psychiatry

4,004

$276K

317
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $124

MIKHAIL PILMAN M.D.

Psychiatry

4,641

$427K

314
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

36%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $124

KATHERINE DUFFY M.D.

Psychiatry

3,244

$352K

314
169 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $124

KUSUM KATHPALIA M.D.

Psychiatry

6,665

$1.02M

314
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 25%

$154
Average prescription price

Avg: $124

MARK DIBUONO MD

Psychiatry

3,973

$536K

310
174 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 25%

$135
Average prescription price

Avg: $124

WALI MOHAMMAD M.D.

Psychiatry

3,506

$227K

307
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $124

EVA KHAVKIN M.D.

Psychiatry

4,341

$557K

302
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

44%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $124

CAILLEAN MCMAHON-TRONETTI DO

Psychiatry

5,237

$1.01M

302
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$192
Average prescription price

Avg: $124

GARY WEINSTEIN MD

Psychiatry

4,581

$489K

297
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

40%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $124

ANDREW REICHERT M.D.

Psychiatry

4,104

$396K

297
146 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 25%

$96
Average prescription price

Avg: $124

LUIS MALDONADO M.D.

Psychiatry

4,024

$491K

295
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$122
Average prescription price

Avg: $124

VILOR SHPITALNIK M.D.

Psychiatry

3,269

$287K

295
115 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

39%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $124

CHARLES VAN METER MD

Psychiatry

5,961

$759K

295
55 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$127
Average prescription price

Avg: $124

LILIAN BELMAN M.D.

Psychiatry

4,143

$294K

294
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

35%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $124

NAGARAJ JAJOOR MD

Psychiatry

4,871

$565K

291
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$116
Average prescription price

Avg: $124

ADAM ASHTON M.D.

Psychiatry

4,129

$830K

290
168 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 25%

$201
Average prescription price

Avg: $124

AARON PINKHASOV M.D

Psychiatry

2,929

$337K

289
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 25%

$115
Average prescription price

Avg: $124

IRINA KOROBOV MD

Psychiatry

4,326

$396K

287
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

47%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $124

SURESH PATIL M.D.

Psychiatry

5,131

$693K

285
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$135
Average prescription price

Avg: $124

EDWARD FRUITMAN MD

Psychiatry

4,247

$824K

285
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 25%

$194
Average prescription price

Avg: $124

DEDENIA YAP MD

Psychiatry

5,946

$560K

285
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $124

MUHAMMAD DAWOOD MD

Psychiatry

3,507

$451K

284
78 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $124

MADHU AHLUWALIA M.D.

Psychiatry

5,765

$745K

283
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $124

SANJAY GUPTA MD

Psychiatry

3,501

$517K

283
103 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 25%

$148
Average prescription price

Avg: $124

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank